Les tumeurs germinales du testicule de stade I : Les tumeurs des organes génitaux externes de l'homme = Stage I Testicular Germ Cell Tumors : Tumours of the Male External GenitaliaFLECHON, A; MOTTET, N.Oncologie (Paris). 2014, Vol 16, Num 4, pp 154-160, issn 1292-3818, 7 p.Article

MDV3100 et cancer de la prostate : La prostate métastatique: de la biologie à la clinique PARTIE I = MDV3100 and prostate cancerFLECHON, A; BOYLE, H.Correspondances en onco-urologie. 2011, Vol 2, Num 3, pp 124-127, issn 2110-087X, 4 p.Article

Cancer du testicule : quelle chimiothérapie, pour quels malades ? = Testis germ cell tumours : which chemotherapy for which patients?FLECHON, A; DROZ, J.-P.Annales d'urologie. 2007, Vol 41, Num 2, pp 56-67, issn 0003-4401, 12 p.Article

Tumeurs germinales du testicule : actualités = Germ cell tumors of the testes : state of the artFLECHON, A; DROZ, J. P.Cancer radiothérapie. 2000, Vol 4, Num 1, pp 27-31, issn 1278-3218Article

Coagulopathy in prostate cancerDE LA FOUCHARDIERE, C; FLECHON, A; DROZ, J-P et al.Netherlands journal of medicine. 2003, Vol 61, Num 11, pp 347-354, issn 0300-2977, 8 p.Article

Chimiothérapie intensive avec support de cellules souches hématopoïétiques dans le traitement des tumeurs germinales : Expérience du centre Léon-Bérard de 1982 à 1996 = High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors : experience of the centre Léon-Bérard between 1982 and 1996FLECHON, A; BIRON, P; PHILIP, I et al.Bulletin du cancer. 1999, Vol 86, Num 4, pp 391-399, issn 0007-4551Article

Actualités dans le cancer de la prostate d'après le cours de Nice Saint-Paul 2013: résistance à la castration, radiothérapie et modélisation du traitement par la biologie et l'imagerie = Update in prostate cancer, from communications of Nice Saint-Paul meeting 2013: focus on castration-resistant prostate cancer, radiotherapy, and treatment modelization based on biology and imagingCULINE, S; BEUZEBOC, Ph; LATORZEFF, I et al.Oncologie (Paris). 2014, Vol 16, Num 9-10, issn 1292-3818, S1-S13, SUP1Article

Prise en charge des tératomes testiculaires: mise au point par le Comité de cancérologie de l'Association française d'urologie groupe organes génitaux externes (CCAFU-OGE) = Management of testicular teratoma: Update by the Oncology committee of the French association of urology, external genital organs group (CCAFU-OGE)AVANCES, C; CAMPARO, P; DURAND, X et al.Progrès en urologie (Paris). 2014, Vol 24, Num 16, pp 1050-1063, issn 1166-7087, 14 p.Article

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trialFLECHON, A; POUESSEL, D; FARGEOT, P et al.Annals of oncology. 2011, Vol 22, Num 11, pp 2476-2481, issn 0923-7534, 6 p.Article

Récidives tardives des tumeurs germinales du testicule = Testicular germ cell tumors late relapsesDURAND, X; AVANCES, C; FLECHON, A et al.Progrès en urologie (Paris). 2010, Vol 20, Num 6, pp 416-424, issn 1166-7087, 9 p.Article

A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumorsTHEODORE, C; CHEVREAU, C; YATAQHENE, Y et al.Annals of oncology. 2008, Vol 19, Num 8, pp 1465-1469, issn 0923-7534, 5 p.Article

Prostate cancer: management of advanced diseaseDROZ, J.-P; FLECHON, A; TERRET, C et al.Annals of oncology. 2002, Vol 13, pp 89-94, issn 0923-7534, 6 p., SUP4Conference Paper

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialBACHNER, M; LORIOT, Y; GILLESSEN, S et al.Annals of oncology. 2012, Vol 23, Num 1, pp 59-64, issn 0923-7534, 6 p.Article

Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancerFIZAZI, K; DE BONO, J. S; HUDES, G. R et al.European journal of cancer (1990). 2012, Vol 48, Num 1, pp 85-93, issn 0959-8049, 9 p.Article

Rôle de la chimiothérapie dans la prise en charge du cancer de la vessie = The role of chemotherapy in the management of bladder cancerISMAILI, N; AMZERIN, M; ELMAJJAOUI, S et al.Progrès en urologie (Paris). 2011, Vol 21, Num 6, pp 369-382, issn 1166-7087, 14 p.Article

Pattern of relapse after first linetreatment of advanced stage germ-cell tumors. CommentaryFLECHON, A; CULINE, S; THEODORE, C et al.European urology. 2005, Vol 48, Num 6, pp 957-964, issn 0302-2838, 8 p.Article

High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment : The French experience : Special Section : UICC Symposium on Testicular CancerFLECHON, A; BIRON, P; DROZ, J. P et al.International journal of cancer. 1999, Vol 83, Num 6, pp 844-847, issn 0020-7136Article

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerBEYER, J; ALBERS, P; COHN-CEDERMARK, G et al.Annals of oncology. 2013, Vol 24, Num 4, pp 878-888, issn 0923-7534, 11 p.Article

Recommandations en onco-urologie 2013 du CCAFU: Tumeurs germinales du testicule = CCAFU Recommendations 2013: Testicular germ cell cancerDURAND, X; RIGAUD, J; COLOBY, P et al.Progrès en urologie (Paris). 2013, Vol 24, issn 1166-7087, S145-S160, SUP2Article

Contribution 2013 du CCAFU au référentiel INCa: Sarcomes du rétropéritoine = CCAFU's contribution to the French National Cancer Institute's reference frame: Retroperitoneal sarcomasAVANCES, C; RIGAUD, J; CAMPARO, P et al.Progrès en urologie (Paris). 2013, Vol 24, issn 1166-7087, S161-S166, SUP2Article

Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT) : results of the sCR2 international studyFIZAZI, K; OLDENBURG, J; TJULANDIN, S et al.Annals of oncology. 2008, Vol 19, Num 2, pp 259-264, issn 0923-7534, 6 p.Article

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface areaPIKETTY, A.-C; FLECHON, A; LAPLANCHE, A et al.British journal of cancer. 2005, Vol 93, Num 8, pp 909-914, issn 0007-0920, 6 p.Article

Cancer du testicule : place de la radiothérapie en 2003 = Testis cancer: role of radiotherapy in 2003CLIPPE, S; FLECHON, A; DROZ, J. P et al.Cancer radiothérapie. 2003, Vol 7, pp 60s-69s, issn 1278-3218, SUP1Conference Paper

Traitements médicaux des cancers de vessie : où va la recherche ? = Medical treatment of bladder cancer : where goes research ?FLECHON, A; DROZ, J. P.Oncologie (Paris). 2000, Vol 2, Num 6-7, pp 380-386, issn 1292-3818Article

Nouveau standard de chimiothérapie dans le traitement des tumeurs germinales non séminomateuses de mauvais pronostic: résultats de l'étude GETUG 13 = New standard of chemotherapy in the treatment of poor prognosis nonseminomatous germ cell tumors: results of GETUG 13 trialFLECHON, A; BOYLE, H.Correspondances en onco-urologie. 2013, Vol 4, Num 4, pp 142-147, issn 2110-087X, 6 p.Article